# Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients

> **NCT03337347** · NA · COMPLETED · sponsor: **The Institute of Molecular and Translational Medicine, Czech Republic** · enrollment: 256 (actual)

## Conditions studied

- Colorectal Cancer
- Circulating Tumor Cell

## Interventions

- **DEVICE:** CTC/DTC count

## Key facts

- **NCT ID:** NCT03337347
- **Lead sponsor:** The Institute of Molecular and Translational Medicine, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01-01
- **Primary completion:** 2007-02-28
- **Final completion:** 2015-10-23
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03337347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03337347, "Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03337347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*